Protecting Your Biotech: Understanding the Risks of Compounded GLP-1s
With the global market for anti-obesity drugs projected to hit $95 billion by 2030, it’s no…
Protecting Your Biotech: Understanding the Risks of Compounded GLP-1s
With the global market for anti-obesity drugs projected to hit $95 billion by 2030, it’s no surprise that compounded semaglutide is gaining traction as a cheaper, more accessible option. But for all its appeal, this route comes with real risks: regulatory uncertainty, legal exposure, and major insurance hurdles. The post Protecting Your Biotech: Understanding the Risks…
Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare
[Sponsored] Get actionable strategies and insights from industry leaders to help payers navigate digital transformation, optimize outcomes, and stay ahead in a value-based care environment. The post Redefining Payer Operations: Data-Driven Strategies for the Future of Healthcare appeared first on MedCity News.
Do You Value MedCity News? Take Our Survey!
Take the MedCity News Audience Survey and share your thoughts. The post Do You Value MedCity News? Take Our Survey! appeared first on MedCity News.
Try This When Your Doctor Says ‘Yes’ to a Preventive Test but Insurance Says ‘No’
“My son was diagnosed with congenital CMV, a virus that can cause hearing loss. As part of this diagnosis, he will be required to have routine hearing tests every few months until he is 10 years old. I reached out to you because I wanted to know why my son’s hearing tests weren’t covered by…
How Older People Are Reaping Brain Benefits From New Tech
It started with a high school typing course. Wanda Woods enrolled because her father advised that typing proficiency would lead to jobs. Sure enough, the federal Environmental Protection Agency hired her as an after-school worker while she was still a junior. Her supervisor “sat me down and put me on a machine called a word…
More Than 100 Organizations Back Bill to Expand Patient Access to Clinical Trials
A coalition of 131 healthcare organizations is backing the Clinical Trial Modernization Act, which aims to expand patient access to clinical trials through financial support and other measures. The post More Than 100 Organizations Back Bill to Expand Patient Access to Clinical Trials appeared first on MedCity News.
Jazz Pharma Broadens Its Prospects in Epilepsy With Deal for Selective Saniona Drug
Saniona’s drug candidate could expand Jazz Pharmaceuticals portfolio in epilepsy. But this preclinical small molecule will need to show advantages in safety and efficacy to compete with Biohaven Pharmaceuticals and Xenon Pharmaceuticals, each with clinical-stage drugs that hit the same epilepsy target. The post Jazz Pharma Broadens Its Prospects in Epilepsy With Deal for Selective…
Faceless Advice, Real Consequences: The Challenge of AI Chatbots in Mental Health
As AI chatbots become a surrogate for human connection amid a national mental health crisis, experts are worried about these tools’ lack of safeguards — with research showing the models can provide dangerous, sometimes fatal, advice. Regulators and providers alike are scrambling to catch up with a technology that evolves faster than humans are able…
Ingrid Lindberg, Sobrynth
Ingrid is one of the OGs of customer service in health plans, PBMs and as she insists startups. She and her co-founder Marin Nelson have built Sobrynth–a company that is taking a whole new approach to helping with (primarily) alcohol addiction in the workplace. Despite the rise of mental health solutions, EAP, the focus on…
Alcohol: Changing use and perceptions
Conventional wisdom holds that alcohol use is part of American culture…but perhaps this is changing. According to a Gallup poll released last week, not only is alcohol use declining but there is an increasing perception that alcohol use is not good for you. While a majority of Americans (54%) still use alcohol, drinking rates are…
